Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Collplant Biotechnologies Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CLGN
Nasdaq
8731
https://www.collplant.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Collplant Biotechnologies Ltd
CollPlant Issues Letter to Shareholders
- Jan 24th, 2023 12:00 pm
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives
- Jan 4th, 2023 12:00 pm
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form
- Jan 3rd, 2023 12:00 pm
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth
- Dec 12th, 2022 2:50 pm
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
- Dec 1st, 2022 12:00 pm
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis
- Nov 15th, 2022 12:00 pm
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3Dâ„¢ 90
- Nov 7th, 2022 12:00 pm
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
- Nov 3rd, 2022 11:00 am
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12
- Oct 3rd, 2022 11:00 am
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy
- Sep 19th, 2022 11:00 am
CollPlant Biotechnologies to Participate in September Investor Conferences
- Sep 6th, 2022 11:00 am
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
- Aug 25th, 2022 11:00 am
We're Hopeful That CollPlant Biotechnologies (NASDAQ:CLGN) Will Use Its Cash Wisely
- Jul 5th, 2022 2:27 pm
CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada
- Jul 5th, 2022 11:00 am
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study
- Jun 29th, 2022 12:45 pm
CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
- May 26th, 2022 11:00 am
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
- May 23rd, 2022 12:00 pm
The 22% return this week takes CollPlant Biotechnologies' (NASDAQ:CLGN) shareholders three-year gains to 141%
- May 21st, 2022 12:59 pm
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening
- Apr 25th, 2022 11:00 am
CollPlant To Present at the Aesthetics Innovation Summit 2022
- Apr 13th, 2022 11:00 am
Scroll